Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug discovery
Biotech
Lilly inks $345M antibody pact with XtalPi subsidiary
The Big Pharma will be able to nominate an undisclosed number of target pairs for bispecific development.
Darren Incorvaia
Nov 5, 2025 7:00am
Lilly, Nvidia team up to build industry-leading supercomputer
Oct 28, 2025 3:26pm
Flagship brings AI drug discovery firm Expedition out of stealth
Oct 22, 2025 8:25am
Turbine looks to turbocharge AstraZeneca's ADC discovery
Oct 9, 2025 6:00am
AstraZeneca, Algen Biotechnologies pen $555M AI pact
Oct 6, 2025 8:00am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
